Tajuk
131-Rituximab RIT for Non Hodgkin Lymphoma
Tahun
2017
Lampiran-lampiran
Executive Summary - I-131-Rituximab RIT for Non Hodgkin Lymphoma.pdf
TR - I-131-rituximab RIT for NHL.pdf